SCHEMBL30068698

SCHEMBL30068698

CC(C)(C)OC(=O)N1CCc2ccc(N)c(Br)c2C1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.60
ESR2 Q92731 1/20 0.55
MAPT P10636 3/20 0.47
KDM4E B2RXH2 1/20 0.47
ADORA1 P30542 2/20 0.46
MAPK1 P28482 1/20 0.43
ABHD6 Q9BV23 2/20 0.42
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 1/20 0.40
F12 P00748 1/20 0.39
RORC P51449 2/20 0.39
MKNK1 Q9BUB5 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
C5AR1 P21730 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25256247 1.00 NR1H2 (0.60) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL31447559 0.90 NR1H2 (0.60) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL17018770 0.90 NR1H2 (0.60) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL31731344 0.88 NR1H2 (0.51) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL19358075 0.88 NR1H2 (0.51) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL30156742 0.85 ESR2 (0.55) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL24913965 0.85 ESR2 (0.55) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL31013907 0.84 ESR2 (0.54) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL31531038 0.83 NR1H2 (0.58) NR1H2ESR2MAPTKDM4EADORA1
SCHEMBL4519564 0.82 NR1H2 (0.60) NR1H2ESR2MAPTKDM4EADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606533-B2 3-phenylpropylamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-04-21 US disclosed
US-20250353824-A1 3-PHENYLPROPYLAMINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-11-20 US disclosed
WO-2022184152-A1 FUSED RING SUBSTITUTED SIX-MEMBERED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 劲方医药科技(上海)有限公司 2022-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353824-A1 3-PHENYLPROPYLAMINE DERIVATIVE SF1, SF3A1, SFXN1 NR1H2 1253/4885ESR2 581/4885MAPT 2719/4885
US-12606533-B2 3-phenylpropylamine derivative SF3A1, SF1, HTR1D NR1H2 470/4885ESR2 161/4885MAPT 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.